Search results for " Program"

showing 10 items of 3075 documents

Cognitive improvement in schizophrenia after 6-month treatment with olanzapine

2008

OlanzapinePsychiatry and Mental healthmedicine.medical_specialtybusiness.industrySchizophrenia (object-oriented programming)medicineCognitionbusinessPsychiatrymedicine.drugEuropean Psychiatry
researchProduct

The miniaturised Mössbauer spectrometer MIMOS IIA: Increased sensitivity and new capability for elemental analysis

2010

The Miniaturised Mossbauer Spectrometers MIMOS II on board the two Mars Exploration Rovers (MER) have now been collecting valuable scientific data for more than five years. Mossbauer Spectrometers are part of two future missions: Phobos Grunt (Russian Space Agency) and a joint ESA—NASA Rover in 2018. The new advanced MIMOS IIA instrument described in this paper uses Silicon Drift Detectors (SDD) allowing also X-ray fluorescence chemical analysis (XRF) simultaneously to Mossbauer acquisitions. This paper highlights the features and technological improvements of the new spectrometer MIMOS IIA.

On boardPhysicsNuclear and High Energy PhysicsSilicon drift detectorSpectrometerElemental analysisMössbauer spectroscopyNondestructive analysisMars Exploration ProgramExploration of MarsInstrumentationRemote sensingNuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment
researchProduct

A Column Generation Approach to Scheduling of Periodic Tasks

2011

We present an algorithm based on column generation for a real time scheduling problem, in which all tasks appear regularly after a given period. Furthermore, the tasks exchange messages, which have to be transferred over a bus, if the tasks involved are executed on different ECUs. Experiments show that for large instances our preliminary implementation is faster than the previous approach based on an integer linear programming formulation using a state-of-the-art solver.

On columnJob shop schedulingComputer scienceColumn generationParallel computingSolverInteger linear programming formulationScheduling (computing)
researchProduct

Comparison of prostate cancer survival in Germany and the USA: can differences be attributed to differences in stage distributions?

2016

Objectives To better understand the influence of prostate-specific antigen (PSA) screening and other health system determinants on prognosis of prostate cancer, up-to-date relative survival (RS), stage distributions, and trends in survival and incidence in Germany were evaluated and compared with the United States of America (USA). Patients and methods Incidence and mortality rates for Germany and the USA for the period 1999-2010 were obtained from the Centre for Cancer Registry Data at the Robert Koch Institute and the USA Surveillance Epidemiology and End Results (SEER) database. For analyses on stage and survival, data from 12 population-based cancer registries in Germany and from the SE…

OncologyAdultMalemedicine.medical_specialtyAdolescentUrologyPopulation03 medical and health sciencesProstate cancerYoung Adult0302 clinical medicineAge DistributionPredictive Value of TestsResidence CharacteristicsInternal medicineGermanymedicineSurveillance Epidemiology and End ResultsHumansMass Screening030212 general & internal medicineeducationMass screeningAgedNeoplasm Stagingeducation.field_of_studyRelative survivalbusiness.industryMortality rateIncidence (epidemiology)IncidenceProstatic NeoplasmsReproducibility of ResultsMiddle AgedProstate-Specific Antigenmedicine.diseasePrognosisUnited StatesCancer registry030220 oncology & carcinogenesisbusinessDemographySEER ProgramBJU international
researchProduct

Interassay and interobserver comparability study of four programmed death-ligand 1 (PD-L1) immunohistochemistry assays in triple-negative breast canc…

2021

Different immunohistochemical programmed death-ligand 1 (PD-L1) assays and scorings have been reported to yield variable results in triple-negative breast cancer (TNBC). We compared the analytical concordance and reproducibility of four clinically relevant PD-L1 assays assessing immune cell (IC) score, tumor proportion score (TPS), and combined positive score (CPS) in TNBC. Primary TNBC resection specimens (n = 104) were stained for PD-L1 using VENTANA SP142, VENTANA SP263, DAKO 22C3, and DAKO 28–8. PD-L1 expression was scored according to guidelines on virtual whole slide images by four trained readers. The mean PD-L1 positivity at IC-score ≥1% and CPS ≥1 ranged between 53% and 75% with th…

OncologyCPS combined positive scoreTC tumor cellsICI immune checkpoint inhibitorTriple Negative Breast NeoplasmsB7-H1 AntigenMedicineHER2 human epidermal growth factor receptor 2Triple-negative breast cancerRC254-282ICC intraclass correlation coefficientbiologyNeoplasms. Tumors. Oncology. Including cancer and carcinogensGeneral MedicineMSI microsatellite instabilityImmunohistochemistrypCR pathological complete responsePFS progression-free survivalImmunohistochemistryOriginal ArticleIC-ScoreIC immune cellsIHC immunohistochemistryProgrammed deathPD-L1medicine.medical_specialtyConcordanceTNBC triple-negative breast cancerOS overall survivalBreast cancerTriple-negative breast cancerPD-L1Internal medicineTPS tumor proportion scoreBiomarkers TumorHumansProgrammed death-ligand 1Reproducibilitybusiness.industryReproducibility of Resultsmedicine.diseaseITT intention to treatCI confidence intervalPD-L1 programmed death-ligand 1biology.proteinSurgeryCPSbusinessKappaTMB tumor mutational burdenBreast
researchProduct

Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO)

2016

The European Society for Medical Oncology (ESMO) is one of the leading societies of oncology professionals in the world. Approximately 30% of the 13 000 ESMO members are below the age of 40 and thus meet the society's definition of young oncologists (YOs). ESMO has identified the training and development of YOs as a priority and has therefore established a comprehensive career development programme. This includes a leadership development programme to help identify and develop the future leaders in oncology. Well-trained and highly motivated future generations of multidisciplinary oncologists are essential to ensure the optimal evolution of the field of oncology with the ultimate goal of pro…

Oncologymedicine.medical_specialtyCancer ResearchReviewFellowshipExecutive boardMultidisciplinary approachInternal medicineJournal ArticleMedicine15061507Leadership developmentbusiness.industryLeadership ProgrammeGénéralitésESMOTraining and developmentYoung OncologistsOncologyESMO; Fellowship; Leadership Programme; Preceptorship; Young OncologistsPreceptorshipPortfoliobusinessCareer developmentESMO; Fellowship; Leadership Programme; Preceptorship; Young Oncologists; Cancer Research; Oncology
researchProduct

In response: Genomic profile of breast cancer.

2015

Response to: Plun-Favreau J, Svedman C, Valentine W, Rouzier R. Genomic profile of breast cancer. Expert Rev Pharmacoecon Outcomes Res 2015;15(3):393–94We would like to express our gratitude for th...

Oncologymedicine.medical_specialtyNational Health Programsmedia_common.quotation_subjectBreast NeoplasmsBreast cancerMammaPrintInternal medicineGratitudemedicineBiomarkers TumorHumansPharmacology (medical)Genetic TestingPrecision Medicinemedia_commonmedicine.diagnostic_testbusiness.industryHealth PolicyGene Expression ProfilingGeneral MedicineHealth Care Costsmedicine.diseaseGenomic ProfileFemaleOncotype DXbusinessExpert review of pharmacoeconomicsoutcomes research
researchProduct

Is there any place for PD-1/CTLA-4 inhibitors combination in the first-line treatment of advanced NSCLC?—A trial-level meta-analysis in PD-L1 selecte…

2021

BACKGROUND: The advent of immuno-oncology (IO) represented a breakthrough in non-small cell lung cancer (NSCLC) therapy over the last few years. However, establishing the optimal therapeutic options among programmed death-ligand 1 (PD-L1) selected subgroups still addresses an unmet need in the clinical setting. METHODS: We performed a systematic review and finally included eleven first-line randomized controlled trials to compare efficacy and safety outcomes among first-line IO treatment strategies versus standard platinum-based chemotherapy (CT) according to PD-L1 expression level (<1%, 1–49%, ≥50%). Pooled hazard ratios (HRs) and risk ratios (RRs) for progression-free survival (PFS), over…

Oncologymedicine.medical_specialtyprogrammed death-1/cytotoxic T-lymphocyte antigen 4 inhibitors (PD-1/CTLA-4 inhibitors)combined modality therapybusiness.industryHazard ratioCombined modality therapy; Immunotherapy; Meta-analysis; Non-small cell lung cancer (NSCLC); Programmed death-1/cytotoxic T-lymphocyte antigen 4 inhibitors (PD-1/CTLA-4 inhibitors)non-small cell lung cancer (NSCLC)Non-small cell lung cancer (NSCLC)medicine.diseaselaw.inventionDiscontinuationmeta-analysisOncologyRandomized controlled triallawRelative riskInternal medicineMeta-analysisMedicineOriginal ArticleimmunotherapybusinessLung cancerAdverse effect
researchProduct

Projekts OpenAIRE un brīvpieejas nodrošināšana Eiropas Komisijas finansēto projektu ietvaros izstrādātajām zinātniskajām publikācijām

2011

Prezentācijā sniegts EK 7. ietvara programmas projekta OpenAIRE raksturojums, mērķi un uzdevumi, iekļauta informācija par Eiropas Komisijas Open Access nostādnēm un pētniecības rezultātu deponēšanu institucionālajos repozitārijos atbilstoši šo nostādņu prasībām.

OpenAIREOpen AccessEiropas Pētniecības padomes Open Access vadlīnijasInstitucionālie repozitārijiEiropas Komisijas 7. ietvara programmas projektiEiropas Komisijas 7. ietvara programmas Open Access nostādnes
researchProduct

A innovative semi-immergible USV (SI-USV) drone for marine and lakes operations with instrumental telemetry and acoustic data acquisition capability

2015

The proposed project shows the results obtained in the implementation and testing in lacustrine and marine environment of a nautical remote controlled vehicle with surface navigation and innovative features Semi-Immersible (SI-USV). This vehicle is based on a pending patent belonging to Palermo University (Patent Pending RM2012A000209 and RM2012A000209) concerning innovative semi-immersible vehicles (SI-Drone), that can be remotely controlled from the ground, air, satellite and sea also during the semi-immersible operation. The vehicle with electric power is coupled with a jet propulsion, given the low draft, makes it possible to navigate in shallow waters or coastal shipping or sandbars. T…

OperabilitySettore ING-IND/11 - Fisica Tecnica Ambientalesemi-immersibleRenewable Energy Sustainability and the EnvironmentvesselPropulsionSettore ING-IND/32 - Convertitori Macchine E Azionamenti ElettriciOceanographyData acquisitionSettore ING-INF/04 - AutomaticaEnvironmental monitoringCommunications satellitesi-usvElectric powerInstrumentation (computer programming)stadam centreUnderwater acousticsGeologyRemote sensingMarine engineering
researchProduct